A detailed history of Deep Track Capital, LP transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Deep Track Capital, LP holds 600,326 shares of KYMR stock, worth $28.7 Million. This represents 1.05% of its overall portfolio holdings.

Number of Shares
600,326
Previous 1,500,000 59.98%
Holding current value
$28.7 Million
Previous $44.8 Million 36.54%
% of portfolio
1.05%
Previous 1.47%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$30.16 - $52.4 $27.1 Million - $47.1 Million
-899,674 Reduced 59.98%
600,326 $28.4 Million
Q2 2024

Aug 14, 2024

BUY
$29.85 - $39.42 $7.1 Million - $9.37 Million
237,754 Added 18.84%
1,500,000 $44.8 Million
Q1 2024

May 15, 2024

BUY
$22.9 - $43.57 $28.9 Million - $55 Million
1,262,246 New
1,262,246 $50.7 Million

Others Institutions Holding KYMR

About Kymera Therapeutics, Inc.


  • Ticker KYMR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,705,800
  • Market Cap $2.61B
  • Description
  • Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...
More about KYMR
Track This Portfolio

Track Deep Track Capital, LP Portfolio

Follow Deep Track Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deep Track Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Deep Track Capital, LP with notifications on news.